A detailed history of New Edge Advisors, LLC transactions in Quanterix Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,100 shares of QTRX stock, worth $11,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,100
Previous 1,155 4.76%
Holding current value
$11,715
Previous $15,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.92 - $16.36 $600 - $899
-55 Reduced 4.76%
1,100 $14,000
Q2 2024

Aug 15, 2024

SELL
$12.26 - $23.78 $6,142 - $11,913
-501 Reduced 30.25%
1,155 $15,000
Q1 2024

May 14, 2024

SELL
$21.9 - $28.28 $12,767 - $16,487
-583 Reduced 26.04%
1,656 $39,000
Q4 2023

Feb 13, 2024

BUY
$19.54 - $28.66 $11,860 - $17,396
607 Added 37.19%
2,239 $61,000
Q3 2023

Nov 14, 2023

BUY
$21.15 - $27.96 $655 - $866
31 Added 1.94%
1,632 $44,000
Q4 2022

Feb 14, 2023

BUY
$8.75 - $14.02 $14,008 - $22,446
1,601 New
1,601 $22,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $394M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.